April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Human Uveal Melanomas
Author Affiliations & Notes
  • Zita Steiber
    Ophthalmology,
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Andrea Treszl
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Gabor Olah
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Armin Buglyo
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Bernadett Rozsa
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Andras Berta
    Ophthalmology,
    University of Debrecen, Debrecen, Hungary
  • Gabor Halmos
    Biopharmacy,
    University of Debrecen, Debrecen, Hungary
  • Footnotes
    Commercial Relationships  Zita Steiber, None; Andrea Treszl, None; Gabor Olah, None; Armin Buglyo, None; Bernadett Rozsa, None; Andras Berta, None; Gabor Halmos, None
  • Footnotes
    Support  Hungarian Scientific Research Fund (OTKA) K 81596 (G.H.) and TAMOP 4.2.1./B-09/1/KONV-2010-0007 project (G.H.), Zoltan Magyary Postdoctoral Fellowship supported by EEA Grants and Norway Grants (A.T.)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6021. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zita Steiber, Andrea Treszl, Gabor Olah, Armin Buglyo, Bernadett Rozsa, Andras Berta, Gabor Halmos; Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Human Uveal Melanomas. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6021.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Treatment options available for patients with advanced uveal melanoma are limited. The presence of luteinizing hormone-releasing hormone (LH-RH) receptors has been demonstrated in various human cancers. Consequently, we investigated the expression of LH-RH ligand and the presence of receptors for LH-RH in tissue samples and cell lines of human uveal melanoma as potential molecular targets for cancer therapy.

Methods: : The expression of LH-RH ligand and LH-RH receptor transcript forms were investigated by RT-PCR using gene specific primers in a panel of human uveal melanoma specimens and 3 cell lines. The presence of LH-RH receptor protein was evaluated by Western blotting.

Results: : The expression of mRNA for LH-RH receptor transcript forms was detected in 17 out of the 38 tissue specimens (47%) and in 2 of 3 cell lines tested. mRNA for LH-RH ligand could be detected in 76% of tissue samples (29 out of 38) and in all 3 cancer cell lines. No PCR products for pituitary type of LH-RH receptors were found. The presence of specific, full lenght LH-RH receptor protein was demonstrated in tumor specimens by Western blotting.

Conclusions: : We were able to detect the expression of LH-RH and transcript forms of LH-RH receptors in human uveal melanomas. Our results support the merit of further investigation of the expression of LH-RH receptors and its transcript forms in human ophthalmological tumors as well as the application of cytotoxic LH-RH analogs for receptor-based targeted therapy of such malignancies. These observations signify the importance of the development of new LH-RH analogs with potential therapeutical applications.

Keywords: melanoma • uvea • receptors: pharmacology/physiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×